busulfan has been researched along with Vascular Diseases in 13 studies
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-four patients had thalassemia major and 4 had SCA." | 5.43 | Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience. ( Ben-Arush, M; Elhasid, R; Khalil, A; Rowe, JM; Zaidman, I, 2016) |
| "BU used to treat patients with acute lymphoblastic leukemia (ALL)." | 2.76 | Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia. ( Chen, YB; Hu, J; Shen, ZX; Tang, W; Wang, L; Zhao, WL, 2011) |
| " Median (range) oral clearance corrected for bioavailability (Cl/F in ml/min/kg), area under the curve (AUC in ng min/ml) and BU plasma concentration (Cp in ng/ml) with the fourth dose were 5." | 2.70 | Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation. ( Abel, S; DeFor, TE; Jacobson, P; Krivit, W; Park, JJ; Peters, C; Thrall, M, 2001) |
| "Seven of 21 patients with sickle cell anemia developed neurologic complications 5 to 243 days (median, 33 days) after allogeneic marrow transplantation." | 2.68 | Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. ( Bernaudin, F; Bunin, N; Johnson, FL; Lenarsky, C; Ohene-Frempong, K; Powars, D; Souillet, G; Sullivan, KM; Vannier, JP; Walters, MC, 1995) |
| " According to our single feature recommendation, following the busulfan dosage was the most effective for preventing VOD/SOS." | 1.72 | Prediction and recommendation by machine learning through repetitive internal validation for hepatic veno-occlusive disease/sinusoidal obstruction syndrome and early death after allogeneic hematopoietic cell transplantation. ( Cho, BS; Cho, SG; Eom, KS; Hwang, HJ; Jung, J; Kim, HJ; Kim, YJ; Lee, E; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, GJ; Park, MS; Park, S; Park, SS; Yoon, JH, 2022) |
| "Thirty-four patients had thalassemia major and 4 had SCA." | 1.43 | Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience. ( Ben-Arush, M; Elhasid, R; Khalil, A; Rowe, JM; Zaidman, I, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, S | 3 |
| Lee, E | 1 |
| Park, SS | 1 |
| Park, MS | 1 |
| Jung, J | 1 |
| Min, GJ | 1 |
| Park, S | 1 |
| Lee, SE | 1 |
| Cho, BS | 1 |
| Eom, KS | 1 |
| Kim, YJ | 1 |
| Kim, HJ | 1 |
| Min, CK | 1 |
| Cho, SG | 1 |
| Lee, JW | 1 |
| Hwang, HJ | 1 |
| Yoon, JH | 1 |
| Remberger, M | 1 |
| Törlen, J | 1 |
| Serafi, IE | 1 |
| Garming-Legert, K | 1 |
| Björklund, A | 1 |
| Ljungman, P | 1 |
| Sundin, M | 1 |
| Hassan, M | 1 |
| Mattsson, J | 1 |
| Strouse, C | 1 |
| Zhang, Y | 1 |
| Zhang, MJ | 1 |
| DiGilio, A | 1 |
| Pasquini, M | 1 |
| Horowitz, MM | 1 |
| Ho, V | 1 |
| Ramanathan, M | 1 |
| Chinratanalab, W | 1 |
| Loren, A | 1 |
| Burns, LJ | 1 |
| Artz, A | 1 |
| Villa, KF | 1 |
| Saber, W | 1 |
| Zaidman, I | 1 |
| Rowe, JM | 1 |
| Khalil, A | 1 |
| Ben-Arush, M | 1 |
| Elhasid, R | 1 |
| Volin, L | 1 |
| Niittyvuopio, R | 1 |
| Heiskanen, J | 1 |
| Lindström, V | 1 |
| Nihtinen, A | 1 |
| Sahlstedt, L | 1 |
| Ruutu, T | 1 |
| Tang, W | 1 |
| Wang, L | 1 |
| Zhao, WL | 1 |
| Chen, YB | 1 |
| Shen, ZX | 1 |
| Hu, J | 1 |
| Barker, CC | 1 |
| Butzner, JD | 1 |
| Anderson, RA | 1 |
| Brant, R | 1 |
| Sauve, RS | 1 |
| Walters, MC | 1 |
| Sullivan, KM | 1 |
| Bernaudin, F | 1 |
| Souillet, G | 1 |
| Vannier, JP | 1 |
| Johnson, FL | 1 |
| Lenarsky, C | 1 |
| Powars, D | 1 |
| Bunin, N | 1 |
| Ohene-Frempong, K | 1 |
| deMagalhaes-Silverman, M | 1 |
| Bloom, EJ | 1 |
| Donnenberg, A | 1 |
| Lister, J | 1 |
| Pincus, S | 1 |
| Rybka, WB | 1 |
| Ball, ED | 1 |
| Jacobson, P | 1 |
| Park, JJ | 1 |
| DeFor, TE | 1 |
| Thrall, M | 1 |
| Abel, S | 1 |
| Krivit, W | 1 |
| Peters, C | 1 |
| Hussain, S | 1 |
| Viala, JJ | 1 |
| Brun, F | 1 |
| Chataing, B | 1 |
| Vallée, G | 1 |
| Boivin, P | 1 |
| Dormont, J | 1 |
| Soulier, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Using Ultrasound Elastography to Predict Development of Sinusoidal Obstruction Syndrome[NCT03858530] | Phase 4 | 100 participants (Anticipated) | Interventional | 2018-05-01 | Active, not recruiting | ||
| Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome[NCT03865589] | 250 participants (Anticipated) | Interventional | 2019-04-01 | Recruiting | |||
| Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients[NCT03963999] | Phase 4 | 0 participants (Actual) | Interventional | 2020-04-01 | Withdrawn (stopped due to We did not receive grant funding. We will reapply in June of 2020) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for busulfan and Vascular Diseases
| Article | Year |
|---|---|
Disorders of hemostasis and thrombosis in the aged.
Topics: Adolescent; Adult; Aged; Aortic Aneurysm; Blood Coagulation Disorders; Blood Coagulation Factors; Bl | 1976 |
5 trials available for busulfan and Vascular Diseases
| Article | Year |
|---|---|
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allografts; Busulfan; Child; Child, Preschool; Female; H | 2018 |
Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Disea | 2011 |
Neurologic complications after allogeneic marrow transplantation for sickle cell anemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Anticonvulsants; Antilymphocyte Serum; Bone Marrow Transplan | 1995 |
Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Busulfan; Combine | 1996 |
Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Busulfan; Child; Child, Preschool; Combin | 2001 |
7 other studies available for busulfan and Vascular Diseases
| Article | Year |
|---|---|
Prediction and recommendation by machine learning through repetitive internal validation for hepatic veno-occlusive disease/sinusoidal obstruction syndrome and early death after allogeneic hematopoietic cell transplantation.
Topics: Busulfan; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Machine L | 2022 |
Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Allografts; Busulfan; Child; Child, Preschool; Cystitis; Female; Hematopoie | 2017 |
Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
Topics: Adolescent; Adult; Anemia, Sickle Cell; beta-Thalassemia; Busulfan; Child; Child, Preschool; Chimeri | 2016 |
Diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome of the liver: problems of interpretation.
Topics: Bilirubin; Biopsy; Busulfan; Cyclophosphamide; Diagnosis, Differential; Hematology; Hepatic Veno-Occ | 2016 |
Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.
Topics: Busulfan; Child; Child, Preschool; Cohort Studies; Cytomegalovirus Infections; Female; Hematologic D | 2003 |
Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.
Topics: Busulfan; Child; Child, Preschool; Cohort Studies; Cytomegalovirus Infections; Female; Hematologic D | 2003 |
Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.
Topics: Busulfan; Child; Child, Preschool; Cohort Studies; Cytomegalovirus Infections; Female; Hematologic D | 2003 |
Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.
Topics: Busulfan; Child; Child, Preschool; Cohort Studies; Cytomegalovirus Infections; Female; Hematologic D | 2003 |
Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.
Topics: Busulfan; Child; Child, Preschool; Cohort Studies; Cytomegalovirus Infections; Female; Hematologic D | 2003 |
Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.
Topics: Busulfan; Child; Child, Preschool; Cohort Studies; Cytomegalovirus Infections; Female; Hematologic D | 2003 |
Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.
Topics: Busulfan; Child; Child, Preschool; Cohort Studies; Cytomegalovirus Infections; Female; Hematologic D | 2003 |
Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.
Topics: Busulfan; Child; Child, Preschool; Cohort Studies; Cytomegalovirus Infections; Female; Hematologic D | 2003 |
Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.
Topics: Busulfan; Child; Child, Preschool; Cohort Studies; Cytomegalovirus Infections; Female; Hematologic D | 2003 |
[The vascular manifestations of polycythemia].
Topics: Adult; Blood Cell Count; Blood Platelets; Busulfan; Female; Gangrene; Humans; Male; Middle Aged; Pho | 1968 |
[Present treatment of the Vaquez's disease].
Topics: Aged; Anemia; Anticoagulants; Antineoplastic Agents; Blood Donors; Blood Volume; Bloodletting; Busul | 1969 |